Literature DB >> 16393991

T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.

Meixiao Long1, Aaron M Slaiby, Adam T Hagymasi, Marianne A Mihalyo, Alexander C Lichtler, Steven L Reiner, Adam J Adler.   

Abstract

When Th1 effector CD4 cells encounter tolerizing Ag in vivo, their capacity to express the effector cytokines IFN-gamma and TNF-alpha is lost more rapidly than noneffector functions such as IL-2 production and proliferation. To localize the relevant intracellular signaling defects, cytokine expression was compared following restimulation with Ag vs agents that bypass TCR-proximal signaling. IFN-gamma and TNF-alpha expression were both partially rescued when TCR-proximal signaling was bypassed, indicating that both TCR-proximal and -distal signaling defects impair the expression of these two effector cytokines. In contrast, bypassing TCR-proximal signaling fully rescued IL-2 expression. T-bet, a transcription and chromatin remodeling factor that is required to direct the differentiation of naive CD4 cells into IFN-gamma-expressing Th1 effectors, was partially down-modulated in tolerized Th1 effectors. Enforcing T-bet expression during tolerization selectively rescued the ability to express IFN-gamma, but not TNF-alpha. Conversely, expression of a dominant-negative T-bet in Th1 effectors selectively impaired the ability to express IFN-gamma, but not TNF-alpha. Analysis of histone acetylation at the IFN-gamma promoter further suggested that down-modulation of T-bet expression during Th1 effector CD4 cell tolerization does not impair IFN-gamma expression potential through alterations in chromatin structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393991      PMCID: PMC2846362          DOI: 10.4049/jimmunol.176.2.1036

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement.

Authors:  Amy D Higgins; Marianne A Mihalyo; Patrick W McGary; Adam J Adler
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

2.  Memory CD8(+) T cells undergo peripheral tolerance.

Authors:  Huub T C Kreuwel; Sandra Aung; Cheryl Silao; Linda A Sherman
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

Review 3.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

4.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

5.  TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.

Authors:  Christian H Poehlein; Hong-Ming Hu; Jane Yamada; Ilka Assmann; W Gregory Alvord; Walter J Urba; Bernard A Fox
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

6.  Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells.

Authors:  W Li; C D Whaley; A Mondino; D L Mueller
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

7.  CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.

Authors:  A J Adler; D W Marsh; G S Yochum; J L Guzzo; A Nigam; W G Nelson; D M Pardoll
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

8.  Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.

Authors:  M G von Herrath; M B Oldstone
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

9.  Conditions that induce tolerance in mature CD4+ T cells.

Authors:  A Lanoue; C Bona; H von Boehmer; A Sarukhan
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

Review 10.  Molecular mimicry and immune-mediated diseases.

Authors:  M B Oldstone
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

View more
  8 in total

1.  CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Authors:  Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

Review 2.  Transcriptional regulatory networks for CD4 T cell differentiation.

Authors:  Darah Christie; Jinfang Zhu
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

3.  Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.

Authors:  Crystal Morales Del Valle; Joseph R Maxwell; Maria M Xu; Antoine Menoret; Payal Mittal; Naomi Tsurutani; Adam J Adler; Anthony T Vella
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

4.  Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.

Authors:  Meixiao Long; Aaron M Slaiby; Shuang Wu; Adam T Hagymasi; Marianne A Mihalyo; Suman Bandyopadhyay; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

5.  Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.

Authors:  Suman Bandyopadhyay; Meixiao Long; Harry Z Qui; Adam T Hagymasi; Aaron M Slaiby; Marianne A Mihalyo; Hector L Aguila; Robert S Mittler; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

6.  Inflammation programs self-reactive CD8+ T cells to acquire T-box-mediated effector function but does not prevent deletional tolerance.

Authors:  Stephanie R Jackson; Jinyun Yuan; Melissa M Berrien-Elliott; Collin L Chen; Jennifer M Meyer; Maureen J Donlin; Ryan M Teague
Journal:  J Leukoc Biol       Date:  2014-05-13       Impact factor: 4.962

7.  The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.

Authors:  Marie-Clare St Rose; Harry Z Qui; Suman Bandyopadhyay; Marianne A Mihalyo; Adam T Hagymasi; Robert B Clark; Adam J Adler
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

8.  In vitro and in vivo differentiated effector CD8 T cells display divergent histone acetylation patterns within the Ifng locus.

Authors:  Suman Bandyopadhyay; Harry Z Qui; Adam J Adler
Journal:  Immunol Lett       Date:  2009-02-03       Impact factor: 3.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.